nVerses Capital »

Iovance Biotherapeutics shares owned by nVerses Capital

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $82k 23k 3.51
2024-09-30 $148k 16k 9.39

More positions owned by nVerses Capital

Lam Research Corp Com New (LRCX)
Ally Financial (ALLY)
Comfort Systems USA (FIX)
Intuitive Surgical Com New (ISRG)
Cintas Corporation (CTAS)
Owl Rock Capital Corporation (OBDC)
Stryker Corporation (SYK)
Jefferies Finl Group (JEF)
Atmus Filtration Technologies Ord (ATMU)
Tsakos Energy Navigation SHS (TEN)
Docusign (DOCU)
A10 Networks (ATEN)
Domino's Pizza (DPZ)
Arista Networks Com Shs (ANET)
Cincinnati Financial Corporation (CINF)

View all positions for nVerses Capital

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Millennium Management
Goldman Sachs Group
Geode Capital Management
Invenomic Capital Management
Bank of America Corporation
D. E. Shaw & Co
Susquehanna International
Palo Alto Investors

View all funds holding Iovance Biotherapeutics